Replies to post #407516 on Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, My belief has always been and remains that the only (and best)
way to optimize uptake of Vascepa (and revenues) is with BP ownership.
Even if Judge Du never made her inane decision JT was not the guy to
GIA (even if that may have been a viable strategy.) An offer right after RI
of anything around $30 would have been fair at that time. Today, a $10
offer would seem reasonable to me. "If" Denner takes two years to sell
the company I hope he would get something closer to $20. However,
as much as we are in the dark about certain aspects of this company
(such as the real situation with Eddingpharm & China) my guess is AD
is in the same situation until "his" BOD can find out the true status and
capabilities of the company. If selling the company sooner rather than
later makes the sense I am all for it. If Denner needs two years to optimize
a BO value I would be for that as well. At least now I am confident that
my goals for this stock are truly aligned with managements!

[rosemountbomber]

GIA became a viable strategy to promote Vascepa in the U.S. and worldwide.

Well maybe in the U.S. (after R-I but before Du) but not worldwide, as we have seen what Amarin has done worldwide and the Du decision has not affected worldwide in any way.

Prior to Judge Du, J.T. would not have accepted an offer for Amarin of $50/sh.

Well, if JT thought that Amarin was that valuable, it would have been a no-brainer to come to some settlement with Hikma before the Du decision even if he pissed of those investors that were supposedly against it (based on that post here on this board reporting such).